Journal
CUREUS JOURNAL OF MEDICAL SCIENCE
Volume 12, Issue 10, Pages -Publisher
SPRINGERNATURE
DOI: 10.7759/cureus.10784
Keywords
rituximab; viral encephalitis; coronavirus disease 2019; acute encephalopathy
Categories
Ask authors/readers for more resources
Central nervous system (CNS) viral infections result in the clinical syndromes of aseptic meningitis or encephalitis. Although the primary target of coronavirus disease 2019 (COVID-19) is the respiratory system, it is increasingly being recognized as a neuropathogen. The hallmark clinical feature is altered mental status, ranging from mild confusion to deep coma. Most patients with encephalopathy or encephalitis are critically ill. We present a case of COVID- 19-related encephalitis who presented with acute delirium and new-onset seizures. The patient responded well to treatment with intravenous immunoglobulins and rituximab.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available